Inactive Instrument
e-therapeutics plc Share Price London S.E.
Stocks
ETX
GB00B2823H99
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -6.74% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | 19/09/2023 | |
Alan Whitmore
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Trevor Jones
CHM | Chairman | 84 | 28/02/2021 |
| Director/Board Member | 70 | 09/02/2020 | |
David Prior
CHM | Chairman | - | 22/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.74% | -7.93% | - | - | 101M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -0.88% | -0.59% | +52.63% | +128.54% | 43.39B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.96% | +138.26% |
Employees
40
